97 related articles for article (PubMed ID: 1674231)
1. Roxatidine acetate as maintenance treatment for patients with peptic ulcer disease. The European Cooperative Roxatidine Study Group.
Clin Ther; 1991; 13(1):47-57. PubMed ID: 1674231
[TBL] [Abstract][Full Text] [Related]
2. A multicenter, double-blind, randomized, placebo-controlled comparison of nocturnal roxatidine in the treatment of active duodenal ulcer disease. Multicenter Roxatidine Cooperative Study Group.
Gilinsky NH; Bright-Asare P; Cobert BL; Fitch DD; Lanza FL; Kerr RM; Savitsky JP
Am J Gastroenterol; 1992 Jul; 87(7):847-53. PubMed ID: 1352083
[TBL] [Abstract][Full Text] [Related]
3. Roxatidine versus ranitidine in the treatment of duodenal ulcer: a randomized, double blind, controlled, multicenter study in Thailand.
Kachintorn U; Chinapak O; Vongphanich V; Kositchaiwat C; Lekhayananda S; Khow-ean U; Suttinont C; Saowaros V; Kludchareon N; Leethochawalit M
J Med Assoc Thai; 1995 Dec; 78(12):641-7. PubMed ID: 8868007
[TBL] [Abstract][Full Text] [Related]
4. New H2-receptor antagonist--roxatidine acetate--in treatment of duodenal ulcer.
Amarapurkar DN; Parikh SS; Desai HG
J Assoc Physicians India; 1993 Aug; 41(8):496-7. PubMed ID: 7904993
[TBL] [Abstract][Full Text] [Related]
5. [Famotidine versus placebo in prevention of the recurrence of duodenal ulcer disease. A multicenter study in Germany, Austria and Italy].
Baglioni A; Barbara L; Bianchi-Porro G; Blasi A; Canelli B; Cheli R; Dal Monte R; Dammann HG; Francavilla A; Hentschel E
Z Gastroenterol; 1985 Dec; 23(12):665-9. PubMed ID: 2868581
[TBL] [Abstract][Full Text] [Related]
6. [Early evening and late evening administration of roxatidine acetate in therapy of duodenal ulcer].
Bosseckert H; Ernst R; Kriech W; Schunter C
Med Klin (Munich); 1993 Nov; 88(11):637-41. PubMed ID: 7905185
[TBL] [Abstract][Full Text] [Related]
7. Roxatidine in duodenal ulcer.
Habibullah CM; Habeeb MA; Singh SP
J Postgrad Med; 1995; 41(3):64-5. PubMed ID: 10707717
[TBL] [Abstract][Full Text] [Related]
8. Roxatidine acetate in the long term maintenance of duodenal ulcers.
Brunner G
Drugs; 1988; 35 Suppl 3():102-5. PubMed ID: 2905238
[TBL] [Abstract][Full Text] [Related]
9. Clinical studies on the use of roxatidine acetate for the treatment of peptic ulcer in Japan.
Inoue M
Drugs; 1988; 35 Suppl 3():114-9. PubMed ID: 2905239
[TBL] [Abstract][Full Text] [Related]
10. Omeprazole in acute and long-term treatment of Asian patients with peptic ulcer refractory to H2-antagonists.
Chelvam P; Wong EC
J Gastroenterol Hepatol; 1989; 4 Suppl 2():75-81. PubMed ID: 2577478
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the efficacy and safety of ebrotidine in the treatment of duodenal ulcer. A multicentre, double-blind, placebo-controlled phase II study.
Gabryelewicz A; Czajkowski A; Skrodzka D; Marlicz K; Luca de Tena F; Aldeguer M; Chantar C; Márquez M; Torres J; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):545-50. PubMed ID: 9205762
[TBL] [Abstract][Full Text] [Related]
12. Comparison of roxatidine acetate and ranitidine in the treatment of reflux esophagitis. The Roxatidine Esophagitis Study Group.
Clin Ther; 1993; 15(2):283-93. PubMed ID: 8100189
[TBL] [Abstract][Full Text] [Related]
13. Effects of changing the type of H2-blocker in the treatment of H2-blocker-resistant ulcers: comparison of roxatidine acetate hydrochloride and other H2-blockers.
Yasutake K; Amano M; Mizokami Y; Kubota S; Fukumoto H; Imamura Y; Yokoya H; Irie K
J Int Med Res; 1998; 26(1):25-36. PubMed ID: 9513074
[TBL] [Abstract][Full Text] [Related]
14. A comparison of roxatidine acetate and ranitidine in duodenal ulcer healing.
Hüttemann W
Drugs; 1988; 35 Suppl 3():90-5. PubMed ID: 2905255
[TBL] [Abstract][Full Text] [Related]
15. Roxatidine acetate in the long term maintenance of gastric ulcers.
Börsch G
Drugs; 1988; 35 Suppl 3():134-8. PubMed ID: 2905242
[TBL] [Abstract][Full Text] [Related]
16. Roxatidine versus ranitidine in the treatment of duodenal ulcers: a randomized double-blind controlled multicentre study in Singapore.
Fock KM; Kang JY; Ng HS; Ng TM; Gwee KA; Lim CC
J Gastroenterol Hepatol; 1995; 10(4):379-82. PubMed ID: 8527701
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics of roxatidine acetate: a review.
Dammann HG; de Looze SM; Bender W; Labs R
Scand J Gastroenterol Suppl; 1988; 146():121-34. PubMed ID: 2906456
[TBL] [Abstract][Full Text] [Related]
18. Ranitidine in the treatment of peptic ulcer.
Makalinao AU; Zaño FM
Clin Ther; 1984; 6(2):185-92. PubMed ID: 6322992
[TBL] [Abstract][Full Text] [Related]
19. Effect of sucralfate on peptic ulcer recurrence: a controlled double-blind multicenter study.
Classen M; Bethge H; Brunner G; Dirr B; Frotz H; Gabor M; Gail H; Grabner R; Hagenmüller F; Heinkel K
Scand J Gastroenterol Suppl; 1983; 83():61-8. PubMed ID: 6356323
[TBL] [Abstract][Full Text] [Related]
20. A multicenter, randomized, double-blind comparison of roxatidine with ranitidine in the treatment of patients with uncomplicated benign gastric ulcer disease. The Multicenter Roxatidine Cooperative Study Group.
Brandstätter G; Marks IN; Lanza F; Kogut D; Cobert B; Savitsky JP; Bender W; Labs R; Wurzer H
Clin Ther; 1995; 17(3):467-78. PubMed ID: 7585851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
